HCID 59511221, 화합물 → ethyl 3-(4-methoxy-3-(2-oxo-2-(4-(1-phenyl-1H-tetrazol-5-yl)piperazin-1-yl)acetyl)-1H-pyrrolo[2,3-c]pyridin-7-yl)-1H-pyrazole-5-carboxylate

HRID 1157287노트

반응식

HRID 1157287 반응식
Cl[C:2]1[N:3]=[CH:4][C:5]([O:32][CH3:33])=[C:6]2[C:10]([C:11](=[O:31])[C:12]([N:14]3[CH2:19][CH2:18][N:17]([C:20]4[N:24]([C:25]5[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=5)[N:23]=[N:22][N:21]=4)[CH2:16][CH2:15]3)=[O:13])=[CH:9][NH:8][C:7]=12.C([Sn](CCCC)(CCCC)[C:39]1[CH:43]=[C:42]([C:44]([O:46][CH2:47][CH3:48])=[O:45])[NH:41][N:40]=1)CCC>O1CCOCC1.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH3:33][O:32][C:5]1[CH:4]=[N:3][C:2]([C:39]2[CH:43]=[C:42]([C:44]([O:46][CH2:47][CH3:48])=[O:45])[NH:41][N:40]=2)=[C:7]2[NH:8][CH:9]=[C:10]([C:11](=[O:31])[C:12](=[O:13])[N:14]3[CH2:19][CH2:18][N:17]([C:20]4[N:24]([C:25]5[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=5)[N:23]=[N:22][N:21]=4)[CH2:16][CH2:15]3)[C:6]=12

참가 물질

5

반응물 2

HCID 59511221HCID 59511221, 화합물HCID 178448219HCID 178448219, 화합물

생성물 1

HCID 24875208ethyl 3-(4-methoxy-3-(2-oxo-2-(4-(1-phenyl-1H-tetrazol-5-yl)piperazin-1-yl)acetyl)-1H-pyrrolo[2,3-c]pyridin-7-yl)-1H-pyrazole-5-carboxylate

시약·촉매·용매 2

HCID 178418397HCID 178418397, 화합물촉매HCID 312751,4-Dioxane용매

반응 조건

온도
120 °C

실험 절차

To a suspension of 1-(7-chloro-4-methoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-(4-(1-phenyl-1H-tetrazol-5-yl)piperazin-1-yl)ethane-1,2-dione (2.50 g, 5.35 mmol) in 1,4-dioxane (60 mL) in a sealable flask was added ethyl 3-(tributylstannyl)-1H-pyrazole-5-carboxylate (2.30 g, 5.36 mmol) followed by tetrakis(triphenylphosphine)palladium(0) (1.86 g, 1.61 mmol). The mixture was flushed with N2, the flask was sealed, and the mixture was heated to 120° C. for 16 hr. The mixture was cooled to rt and diluted with MeOH (50 mL). The remaining solids were removed by filtering the mixture through a pad of celite and were washed with MeOH (25 mL). The remaining solvent was concentrated under reduced pressure. The resulting residue was dissolved in MeOH, and loaded onto a silica gel. After the silica was dry, a column was run using the biotage system with a 0 to 10% MeOH in CH2Cl2 gradient. After concentrating the desired fractions, 1.05 g of ethyl 3-(4-methoxy-3-(2-oxo-2-(4-(1-phenyl-1H-tetrazol-5-yl)piperazin-1-yl)acetyl)-1H-pyrrolo[2,3-c]pyridin-7-yl)-1H-pyrazole-5-carboxylate was recovered as an orange solid. LCMS: m/e 571.2 (M+H)+, ret time 2.01 min (method 2). 1H NMR (500 MHz, DMSO-D6) δ ppm 12.39-12.72 (m, 1 H) 8.37 (s, 1 H) 8.11 (s, 1 H) 7.52-7.76 (m, 6 H) 4.68-4.85 (m, 1 H) 4.38 (q, J=7.02 Hz, 2 H) 3.98-4.06 (m, 3 H) 3.67-3.73 (m, 2 H) 3.43-3.49 (m, 2 H) 3.28-3.36 (m, 2 H) 3.14-3.22 (m, 2 H) 1.36 (t, J=7.17 Hz, 3 H).

후처리

  1. customThe mixture was flushed with N2
  2. customthe flask was sealed
  3. temperatureThe mixture was cooled to rt
  4. additiondiluted with MeOH (50 mL)
  5. customThe remaining solids were removed
  6. filtrationby filtering the mixture through a pad of celite
  7. washwere washed with MeOH (25 mL)
  8. concentrationThe remaining solvent was concentrated under reduced pressure
  9. dissolutionThe resulting residue was dissolved in MeOH
  10. customAfter the silica was dry
  11. concentrationAfter concentrating the desired fractions, 1.05 g of ethyl 3-(4-methoxy-3-(2-oxo-2-(4-(1-phenyl-1H-tetrazol-5-yl)piperazin-1-yl)acetyl)-1H-pyrrolo[2,3-c]pyridin-7-yl)-1H-pyrazole-5-carboxylate
  12. customwas recovered as an orange solid
  13. customm/e 571.2 (M+H)+, ret time 2.01 min (method 2)

출처 및 근거

ORD 기록
ord-42b2500a38004741bd0714634df89ac9
출처 데이터셋
uspto-grants-2010_10
특허 번호
US07807671B2

반응 노트

불러오는 중…